Dr Yolande Glutathione
50% of the psyche drugs need 2D6 to metabolize,
those who are found to be poor metabolizers, missing 2D6 should not be
[and what about the tylenol that is given before
and after vaccines (which depletes glutathione from liver, which is necessary
From: Eileen Dannemann <firstname.lastname@example.org>
Dr. Yolande Lucire is in our network. She is a foresensic psychiatrist,
Phd researcher in pharmacogenetics. She basically saved my son David Dannemann
who was misdiagnosed as bipolar after experimenting with LSD at 19 years old.
He was in and out of the University of Iowa psyche ward; given drugs like Haldol,
Tradazone, Adavan....all requiring the gene Cytochrome P450 2D6 to metabolize.
For years he was being dumbed down and made incoherent until Dr. Lucire
facilitated a simple gene test (swabbing the mouth). He was indeed missing all
2D6 activity and therefore was being poisoned and having suicidal ideations,
being arrested, thrown into the psyche wards. He is now recovering by
withdrawing all prescription drugs....thanks to Dr. Lucire.
The interesting thing I found was that the glutathione pathway implicated in
vaccine injury/ Autism Spectrum is found on the same cytochrome 450. Vaccines
are so toxic that if someone is a poor metabolizer they will sustain a vaccine
injury; then get misdiagosed as ADHD, ADD, etc and then given harmful life
Why this is so HUGE...is because all of us know people who are taking
anti depressants, SSRIs, and ADHD medication, especially the kids these days.
Special needs education is at an all time high!
Kids who do street drugs to experiment like David did and are missing their 2D6
activity...act so strange that invariably the parent takes them to the Doctor
and they get their own prescription. And then they get worse, apparently more
psychotic, but that is because they have no metabolic activity. As they appear
more psychotic they get more of a cocktail of drugs and their lives go down
hill. This goes for depressed adults too.
Education and a standard of care protocol to test a person before giving
vaccines or psyche drugs has been suppressed in the medical industry and to the
public. Homicides, suicides are moving upward at an alarming rate. Some drugs
(and far from how many should be) are labled as suicidal. That is because a
substantial percentage of people who are taking these drugs are poor
Look at this link and on the Mayo clinic link- as much as 50% of the psyche
drugs need 2D6 to metabolize. This is a pharma-medical coverup of an egregious
kinds. There is also a list of the drugs that must be metabolized by 2D6.
Missing 2D6 is not a debility. I believe it is an evolutionary issue. 30% of
Tanzanian Africans have evolved to have multiple 2D6 because they eat a lot of
weeds as growing food is difficult in that area. So they are basically eating
alot of source medication. They have become ULTRA RAPID METABOLIZERS.
Those who are found to be poor metabolizers, missing 2D6 should not be
vaccinated; should not use street or prescription drugs; should stay away
from toxic substances and eat organic food. Notice that these are the natural
attitudes of the enlightened. Nature slam dunks the highly moral and spiritual
when they stray from the high path...I think the missing 2D6 is a corresponding
physical condition of a certain spiritual proclivity and a blessing for all
those incarnating into the greatest DRUG EPOCH in the history of mankind.
If you or your loved ones are having "apparent" mental problems
get tested. It cost only $290.00 at this time in Australia at the lab Dr.
Lucire uses. Read more on our site about 2D6, Dr. Lucire's recent published
study (riveting) on homicides and 2D6, and the Mayo Clinic:
Below read about the great australian whistleblow, Dr. Yolande Lucire who is in
opinion - Australia's e-journal of social and political debate
Whistleblower in Coventry: Dr Yolande Lucire and Big Pharma
By Peter King
Posted Monday, 20 December 2010
Australia lags well behind the US and Britain in facing up to the
malfeasance of multinational drug companies pushing unsafe products. Very often
Big Pharma itself has largely conjured up the booming markets in which its
dubious drugs offer expensive treatment for dubious medical conditions.
The biggest and most lucrative scandals have been in two types of
second-generation drugs: anti-depressants or SSRIs - Prozac, Paxil, Zoloft, etc,
and "atypical" antipsychotics such as Zyprexa, Risperdal and Seroquel which were
known from their licensing to be ineffective for the vast majority of clinical
trial subjects and up to twice as bad for inducing suicide as antidepressants.
The corrupt drug trial and marketing practices of Big Pharma include imaginary
science (the serotonin deficiency theory of depression), systematic suppression
of lethal side effects (akathisia - cannot-sit-down restlessness - leading to
suicidal ideation, suicide and murder) and a multi-billion dollar success over
the past generation in medicalising the ordinary ups and downs of the human
Feeling sad? ("Moderate depression", worthy of a happy little Zoloft rock.)
Diffident? ("Social anxiety disorder", try Aropax.) If antidepressants cured any
significant number of people there would be significantly less cost and less
demand for mental health services in Australia. Whether from inadequate or
tendentious pharmacology training, laziness, busyness, greed driven by willed
ignorance or even misplaced conviction, the medical profession has succumbed to
the cynical marketing and the targeted blandishments of the pharmaceutical
Medical and scientific journals from Nature to The New England Journal
of Medicine allowed their columns to be infiltrated for years by blatantly
dishonest research reporting and ghost written articles commissioned in
Pharma-land but signed by distinguished professors frequently in receipt of
seven-figure research and consultancy funding. Most of these journals do now
take another tack, debunking Pharma claims and exposing fraudulence. But many
medical professional bodies are still being subsidised beyond hope of objective
dealing with the issue of mass iatrogenesis caused by dud drugs andmultiple drug
prescribing ("polypharmacy"), and particularly with the lethal side effects of
The key drug regulator in the US - and the planet - the United States Food and
Drug Administration (US FDA) has failed to purge the Pharma-friendly experts who
have dominated its rulings up to now. Our own Therapeutic Goods Administration
obediently follows suit, also licensing drugs largely on information provided by
their makers. But in America the going has been getting perceptibly harder for
the drug companies.
Whistleblowers, class actions and litigious state governments confronting
ballooning health costs have been taking a toll on profits. Pfizer was recently
fined $US2.3 billion for fraudulently promoting four drugs including the
"antipsychotic" Zeldox last year. This fine is seriously denting Pfizer's bottom
(net income) line of $US8 billion, and whistleblowers, including former Pfizer
employees, collected over $US100 million for their pains in this case - a big
threat to Pharma for the future.
Although such a fine has been described in a recent British Medical Journal
as"firing 22s into the arse of a rhino" and Pfizer has been called "too big to
nail" (only a Pfizer subsidiary pleaded guilty to criminal charges), drug
companies face a rising tide of multi-billion dollar class actions and the
prospect of new laws which could put them out of business. The original
whistleblowers who were listened to have made the key difference in the United
States. Robert Whitaker traced the suicide epidemic and mental health cost
blow-out following the launch of Prozac in 1988. The quiet Irishman, David
Healy, exposed drug trial fakery and the vast, hidden collateral damage of
pharma's SSRI bonanza in the 1990s and later.
These two and others have engineered a paradigm shift in public understanding,
and professorial heads in receipt of undeclared consultancy riches have started
to roll at research institutes and universities in the US, including even
Harvard. According to the New York Times, Dr Joseph Biederman, the
pioneer of "aggressive diagnosis and drug treatment of childhood bipolar
to report most of the $1.6 million he received in pharma funding over
several years while at Harvard.
The single person who has been trying hardest to fill the Whitaker/Healy
whistleblower gap in Australia is Sydney psychiatrist, Dr Yolande Lucire.
Thirteen years ago she began to notice alarmingly high hospital admission and
suicide rates among patients treated with SSRIs and atypical antipsychotics in
New South Wales's Greater Southern Area Health Service. Since then she has been
fighting back against the Pharma-driven psychiatric consensus that treating with
SSRIs is safe and effective, working hard to wean patient-victims as well as
their prescribers off the drugs.
She has steadily accumulated damning statistics on suicide, homicide and
hospitalisation rates among these patients in New South Wales. More recently
it has become clear that a large percentage of people being treated with
antidepressants can't metabolise them due to common genetic mutations. Dr Lucire
has been campaigning to introduce systematic doctor education in order to
minimise promiscuous and uninformed anti-depressant prescribing. With her
complaints, findings and warnings about lack of action, Dr Lucire has been
assiduously lobbying her colleagues, the Medical Board and the Health Care
Complaints Commission of NSW, the Adverse Drug Reactions Advisory Committee (ADRAC)
of the federal Therapeutic Goods Administration and a clutch of ministers, both
state and federal, for many years. Most recently she has been providing redacted
files on her own extensive sample of DNA swab-tested relapsing patients
suffering from the side effects of SSRIs and polypharmacy.
And she has had one notable victory in the political arena. Under
pressure from Dr Lucire, the secretary of Health and Ageing set up an inquiry
early in 2009 into 90 of her serious adverse drug reaction reports, which
occurred mainly in normal folk treated for stress and other vicissitudes of life
and who had become suicidal and/or homicidal on antidepressants. The Psychiatric
Drug Safety Expert Advisory Panel reported in December last year, confirming her
concerns about the near-universality of ignorant polypharmacy and dangerous
gene-based drug-drug interactions leading to akathisia, suicide and homicide and
all the mental states preceding them.But its recommendations are still waiting
to be noticed by the NSW Medical Board and Department of Health.
So far the Medical Board seems to have quite other ideas about Dr Lucire's
contribution to public health than the Advisory Panel. In July 2007 one of the
many patients she was trying to save from another bout of potentially lethal
akathisia killed her own father and sister. In her view, this patient's
akathisia was initially caused by the polypharmacy which had previously
aggravated her mental condition. But this case led to Medical Board proceedings
against her. She has concerns about the board's procedures and why she is being
At the core of her alleged delinquency are charges that she has failed to
recognise that SSRI treatment is "standard practice" - also "best practice";
that she has "unusual beliefs (read: not good for the professional bottom line)
about the side effects of psychotropic medication"; that she is "lacking in
respect for colleagues' diagnoses", and has been "guilty of destroying patients"
confidence in their treating doctor" (while saving their sanity and/or lives,
could we add?).
Galileo would have been familiar with this kind of stuff. What Dr Lucire's
hostile critics, like Galileo's, have not done is respond professionally to her
criticisms in scientific terms. Could they be scared of the result? Dr Lucire
continues to draw attention to the causes of the public mental health problem,
albeit at times in a naive, didactic or exasperated manner, as she admits
herself. She has good grounds for paranoia, but she is unwise to be forever
saying that no-one takes any notice of her (fully justified) Cassandra-like
warnings. The Expert Advisory Panel did; some fair-minded journalists do, and
also a sprinkling of academics in science based disciplines.
She is appealing the latest tribunal decision in the Supreme Court of New South
Wales backed with character references by a Who's Who of people wise to the ways
of corporate money in the medical professions and familiar with the differences
between majority views and what is scientifically established in psychiatry. Dr
Lucire also persists in trying to stymie the campaign currently building around
the country to drastically expand hospital and clinical services for the
Prominent in this campaign are Australian of the Year 2010, Professor Patrick
McGorry of Melbourne University and headspace, and Professor Ian Hickie
of the Brain and Mind Research Institute at Sydney University and the SPHERE
national depression initiative.
Patrick McGorry is a proponent of early drug intervention to combat youth
depression. Ian Hickie is an outspoken and genuinely concerned intervener in a
wide array of debates on the social health of Australia and Australians, most
recently concerning the fate of badly accommodated university students.
But his Brain and Mind Institute was lately discovered by The
Australian to be
housing Lifeblood, a private company helping the pharmacy industry
spend $75 million on "doctors' education". Lifeblood has boasted on its
website that SPHERE, "a mental health program undertaken by 12,000 GPs since
1998", of which both Pfizer and the Brain and Mind Research Institute are
commercial partners, has restored Pfizer's Zoloft to market leadership in the
anti-depressant stakes. Hickie himself was the architect of the controversial
(and Bristol Myers Squibb funded) "depression screening tool" (a checklist of
questions for GPs) used in SPHERE.
How awkward this all must be for his institute - and for your (and my) Sydney
University, which also boasts a Pfizer/PPF Chair of Pharmacy Management and a
Pfizer Australian Chair in Clinical Pharmacy. Professor Hickie also co-authored
the Royal Australian and New Zealand College of Psychiatrists' original (2003)
recommended guidelines for treatment of depression, whose clarion call was:
"Depression is common, serious and treatable. It affects 1 in 25 people in any 1
month." These RANZCP guidelines recommended that even "moderately severe"
depression should be treated with Nefazadone, a drug which was withdrawn four
months later because of fatal side effects. Very few specific side effects or
drug-drug interactions were reported in these guidelines, which have been only
cosmetically improved in their 2009 version for the “consumer and carer”.
The RANZCP guidelines (and near identical ones around the world) emerged from
the Texas of Governor George W Bush where they became mandatory in the treatment
of prisoners and public mental patients following a lavish lobbying campaign
under the rubric of the Texas Medication Algorithm Project by Big Pharma.
According to Dr Lucire, the notion of applying algorithms or "one size fits all"
to a genetically diverse population in the days of personalised medicine borders
What is first and most needed in Australia's so far depressing, big American,
Pharma driven approach to depression is not more of the same but less.
Antidepressants used for anything less then severe depression, and closely
monitored, are an expensive, ineffective (less than three per cent more
effective than placebo in clinical trials presented to the US Food and Drug
Administration for their licensing) and dangerous family of drugs whose side
effects and addictive qualities have triggered a serious crisis in public health
- not least by an explosion of hospital beds for unrecognised side effect
The highway to massive cost savings - and effective redirection of public
spending on mental health - is to break the addiction of psychiatrists, doctors,
medical bureaucracies and patients to the notion that there is a pill for every
ill. Dr Lucire's professional martyrdom may well continue short term. But
developments in the US suggest that her brave and brilliant efforts in this
direction, however casually and cynically denigrated, will eventually prevail
here. There will be many and much to answer for if justice for her and the
Australian victims of the SSRI scourge is long delayed.
Peter King is convener of the West Papua Project at Sydney University and
the author of West Papua and Indonesia since Suharto: Independence, Autonomy
or Chaos? (UNSW Press)
© The National Forum and contributors 1999-2011. All rights reserved.
Director, National Coalition of Organized Women